Tumor-infiltrating CD4+T cells and CD8+T cells were correlated with superior prognosis of breast cancer, colorectal cancer, glioblastoma, and cervical cancers (Saito et al., 2016; Maimela et al., 2019). This evidence concerns the gene CD8A and neoplasm.